Medvadis Research | Waltham, MA
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK master protocol) including a subset of participants who have obstructive sleep apnea (OSA) (J1I-MC-GSA2). The study will last about 89 weeks and will include up to 24 visits.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
GSA2 Inclusion Criteria
Exclusion criteria
GSA2 Exclusion Criteria
Primary purpose
Allocation
Interventional model
Masking
1,000 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal